Akèy › Sipwa › Lwizyàn › Baton Rouge
Etid klinik pou Sipwa nan Baton Rouge, LA
10 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Baton Rouge (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Ap rekriteFaz 3
- Pennington Biomed Res Ctr, Baton Rouge
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Ap rekriteFaz 3
- Southern Clin Research, Zachary · 14 mi lwen
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Ap rekriteFaz 3
- Pennington Biomedical Research Center, Baton Rouge
Impact of Lean Pork on Endothelial Function in Perimenopause
Ap rekriteVolontè an sante akeyi
- Pennington Biomedical Research Center, Baton Rouge
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Baton Rouge
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Baton Rouge
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Velocity Clinical Research - Baton Rouge, Baton Rouge
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Ap rekriteFaz 3
- Pennington Biomedical Research Center, Baton Rouge
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Ap rekriteFaz 3
- ACCOMPLISH-1 Research Site, Baton Rouge
Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding
Ap rekriteVolontè an sante akeyi
- Pennington Biomedical Research Center, Baton Rouge
Etid Sipwa nan lòt vil
- San Antonio, TX34 etid
- Houston, TX33 etid
- Chicago, IL28 etid
- Orlando, FL27 etid
- Las Vegas, NV23 etid
- Miami, FL23 etid
- Atlanta, GA20 etid
- Dallas, TX20 etid
- New York City, NY19 etid
- Jacksonville, FL19 etid
- Washington, DC19 etid
- Austin, TX18 etid
Lòt etid nan Baton Rouge
- Obèsite16 etid
- Kansè Poumon ki pa ti selil10 etid
- Kansè Metastatik9 etid
- Kansè poumon8 etid
- Leksemi mieloïd egi8 etid
- Kansè kolorektal8 etid
- Kansè nan tete7 etid
- Kansè vejik6 etid
- BPCO5 etid
- Kansè pwostat5 etid
- Lukemi lenfositè kwonik5 etid
- Ensifizyans kadyak5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.